Franklin Resources
ACET icon

Franklin Resources’s Adicet Bio ACET Stock Holding History

Franklin Resources’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.27M Hold
626,571
– – ﹤0.01% 1598
2025
Q4 		$5.28M Buy
+626,571
New +$6.93M ﹤0.01% 1379

Other funds holding ACET

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Franklin Resources's ACET Position: Q1 2026 in Review

Franklin Resources held its Adicet Bio (ACET) position steady in Q1 2026 at 626,571 shares worth $4.27M. The position accounts for ﹤0.01% of the portfolio, ranked #1598.

Franklin Resources first reported a position in ACET in Q4 2025 and has held it in 2 quarters since. The position peaked at $5.28M in Q4 2025. 49 funds tracked by Wall St. Rank hold ACET as of Q1 2026.

  • Franklin Resources held 626,571 shares of Adicet Bio worth $4.27M as of Q1 2026.
  • Franklin Resources left its Adicet Bio share count unchanged in Q1 2026.
  • Adicet Bio made up ﹤0.01% of Franklin Resources's portfolio in Q1 2026, its #1598 holding.
  • Franklin Resources first reported a position in Adicet Bio in Q4 2025 and has held it in 2 quarters since.
  • Franklin Resources's Adicet Bio position peaked at $5.28M in Q4 2025.
  • 49 funds tracked by Wall St. Rank held Adicet Bio as of Q1 2026.

Based on Franklin Resources's 13F filing for Q1 2026, filed 13 May 2026.